Are Your Cold Chain Technologies Up to the Task of Global Distribution?

Cold chain technologies serve an important role for a myriad amount of industries, particularly retail and shipment. Cold chain refers to a temperature-managed supply chain. An untarnished cold chain is an uninterrupted collection of storage and distribution processes that maintain a certain range of temperature. It is mainly utilized to assist in extending and guaranteeing the shelf life of goods that are shipped and exported to distant places. Goods vary immensely from agricultural products, seafood, frozen food, photo films and even pharmaceutical products, such as vaccines.

These technologies are commonly used for in the food and drug industries as well as several chemical shipments. The typical temperature range for cold chains technology in the field of pharmaceuticals is 2 to 8°C yet the certain temperature and time at temp tolerances rely upon the real product being delivered overseas. This is vital in the supply of vaccines to distant hospitals and medical institutions in hot weather conditions enveloped by poorly developed transportation systems. Efficient vaccine distribution and storage are crucial to accomplishing immunization scope and effect. As new and costlier vaccines become available, greater capacity is relatively demanded for cold chains technology to conform to the latest vaccines. Furthermore, with the high financial risks involved, the loss of vaccines associated with climate damage is becoming unacceptable. Cutting edge chain technology can support the improvement in dependability of vaccine dissemination, lower unneeded wastage of invaluable vaccines and other pharmaceutical drugs and support the empowerment of the overall immunization networks.

The importance of this process has become apparent in different situations in the past. Disruption of cold chains execution as a result of a war may generate consequences identical to the Smallpox outbreak in the Philippines during the US-Spanish war. Conventionally, all historical stability information facilitated for vaccines was derived from the standard temperature range between 2 to 8­°C. With previous development of biological goods by former vaccine manufacturers, biological affairs had fallen into identical classifications of storage at 2 to 8°C because of the technicality of the products and the insufficiency of testing these goods at broader storage circumstances.